{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:45:03Z","timestamp":1759693503327},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3379,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1080\/08035250500459717","type":"journal-article","created":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T21:48:50Z","timestamp":1138916930000},"page":"701-706","source":"Crossref","is-referenced-by-count":9,"title":["Avidity of Tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia \u2013 implications for vaccination strategies"],"prefix":"10.1111","volume":"95","author":[{"given":"Torben","family":"Ek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotta","family":"Mellander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Hahn-Zoric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"E00001","unstructured":"Saarinen-Pihkala, UM and Gustafsson, G and Carlsen, N and Flaegstad, T and Forestier, E and Glomstein, A and (2004) Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation <i>Pediatr Blood Cancer<\/i>, 42, pp. 8 - 23."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Gustafsson, G and Kreuger, A and Clausen, N and Garwicz, S and Kristinsson, J and Lie, SO and (1998) Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO) <i>Acta Paediatr<\/i>, 87, pp. 1151 - 61.","DOI":"10.1111\/j.1651-2227.1998.tb00923.x"},{"key":"E00003","unstructured":"von der Hardt, K and Jungert, J and Beck, JD and Heininger, U. (2000) Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents\u2013a retrospective analysis <i>Vaccine<\/i>, 18, pp. 2999 - 3004."},{"key":"E00004","unstructured":"Smith, S and Schiffman, G and Karayalcin, G and Bonagura, V. (1995) Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy <i>J Pediatr<\/i>, 127, pp. 68 - 75."},{"key":"E00005","unstructured":"Feldman, S and Andrew, M and Norris, M and McIntyre, B and Iyer, R. (1998) Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia <i>Clin Infect Dis<\/i>, 27, pp. 388 - 90."},{"key":"E00006","unstructured":"Nilsson, A and De Milito, A and Engstrom, P and Nordin, M and Narita, M and Grillner, L and (2002) Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens <i>Pediatrics<\/i>, 109, pp. e91."},{"key":"E00007","unstructured":"Zignol, M and Peracchi, M and Tridello, G and Pillon, M and Fregonese, F and D'Elia, R and (2004) Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy <i>Cancer<\/i>, 101, pp. 635 - 41."},{"key":"E00008","unstructured":"Brodtman, DH and Rosenthal, DW and Redner, A and Lanzkowsky, P and Bonagura, VR. (2005) Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens <i>J Pediatr<\/i>, 146(5), pp. 654 - 61."},{"key":"E00009","unstructured":"Ek, T and Mellander, L and Hahn-Zoric, M and Abrahamsson, J. (2004) Intensive Treatment for Childhood Acute Lymphoblastic Leukemia Reduces Immune Responses to Diphtheria, Tetanus, and Haemophilus influenzae Type b <i>J Pediatr Hematol Oncol<\/i>, 26, pp. 727 - 34."},{"key":"E00010","unstructured":"Feldman, S and Gigliotti, F and Shenep, JL and Roberson, PK and Lott, L. (1990) Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine <i>J Infect Dis<\/i>, 161, pp. 926 - 31."},{"key":"E00011","unstructured":"Heath, PT and Booy, R and Griffiths, H and Clutterbuck, E and Azzopardi, HJ and Slack, MP and (2000) Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood <i>Clin Infect Dis<\/i>, 31, pp. 973 - 80."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Schlesinger, Y and Granoff, DM. (1992) Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group <i>JAMA<\/i>, 267, pp. 1489 - 94.","DOI":"10.1001\/jama.1992.03480110065035"},{"key":"E00013","unstructured":"Breukels, MA and Jol-van der Zijde, E and van Tol, MJ and Rijkers, GT. (2002) Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed <i>Clin Infect Dis<\/i>, 34, pp. 191 - 7."},{"key":"E00014","unstructured":"Mellander, L and Bottiger, M and Hanson, LA and Taranger, J and Carlsson, B. (1993) Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content <i>Acta Paediatr<\/i>, 82, pp. 552 - 6."},{"key":"E00015","unstructured":"Goldblatt, D and Vaz, AR and Miller, E. (1998) Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization <i>J Infect Dis<\/i>, 177, pp. 1112 - 5."},{"key":"E00016","unstructured":"Abrahamsson, J and Carlsson, B and Mellander, L. (1999) Serum antibody levels and avidities to Escherichia coli O antigens and poliovirus type 1 antigen are increased in children treated for malignant disease <i>Med Pediatr Oncol<\/i>, 32, pp. 416 - 20."},{"key":"E00017","unstructured":"Galazka, AM.(1993) <i> The immunological basis for immunization series (3): Tetanus. Expanded programme on immunization<\/i>. WHO Geneva 1993."},{"key":"E00018","unstructured":"Kayhty, H and Peltola, H and Karanko, V and Makela, PH. (1983) The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b <i>J Infect Dis<\/i>, 147, pp. 1100."},{"key":"E00019","unstructured":"Plotkin, SA. (2001) Immunologic correlates of protection induced by vaccination <i>Pediatr Infect Dis J<\/i>, 20, pp. 63 - 75."},{"key":"E00020","unstructured":"Pullen, GR and Fitzgerald, MG and Hosking, CS. (1986) Antibody avidity determination by ELISA using thiocyanate elution <i>J Immunol Methods<\/i>, 86, pp. 83 - 7."},{"key":"E00021","unstructured":"Roberton, DM and Carlsson, B and Coffman, K and Hahn-Zoric, M and Jalil, F and Jones, C and (1988) Avidity of IgA antibody to Escherichia coli polysaccharide and diphtheria toxin in breast milk from Swedish and Pakistani mothers <i>Scand J Immunol<\/i>, 28, pp. 783 - 9."},{"key":"E00022","unstructured":"Slifka, MK and Antia, R and Whitmire, JK and Ahmed, R. (1998) Humoral immunity due to long-lived plasma cells <i>Immunity<\/i>, 8, pp. 363 - 72."},{"key":"E00023","unstructured":"Ahmed, R and Gray, D. (1996) Immunological memory and protective immunity: understanding their relation <i>Science<\/i>, 272, pp. 54 - 60."},{"key":"E00024","unstructured":"Crotty, S and Felgner, P and Davies, H and Glidewell, J and Villarreal, L and Ahmed, R. (2003) Cutting edge: long-term B cell memory in humans after smallpox vaccination <i>J Immunol<\/i>, 171(10), pp. 4969 - 73."},{"key":"E00025","unstructured":"Hammarlund, E and Lewis, MW and Hansen, SG and Strelow, LI and Nelson, JA and Sexton, GJ and (2003) Duration of antiviral immunity after smallpox vaccination <i>Nat Med<\/i>, 9, pp. 1131 - 7."},{"key":"E00026","unstructured":"Abrahamsson, J and Mellander, L. (1997) Bone marrow immunoglobulin-secreting cells are not reduced in children with leukaemia as compared to children with solid tumours <i>Acta Paediatr<\/i>, 86, pp. 165 - 9."},{"key":"E00027","unstructured":"Bachmann, MF and Kalinke, U and Althage, A and Freer, G and Burkhart, C and Roost, H and (1997) The role of antibody concentration and avidity in antiviral protection <i>Science<\/i>, 276, pp. 2024 - 7."},{"key":"E00028","unstructured":"Fioredda, F and Plebani, A and Hanau, G and Haupt, R and Giacchino, M and Barisone, E and (2005) Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy <i>Eur J Haematol<\/i>, 74, pp. 20 - 3."},{"key":"E00029","unstructured":"Immunisation of the Immunocompromised Child Best Practice Statement. In:Royal College of Paediatrics and Child Health; 2002."},{"key":"E00030","unstructured":"Graubner, UB and Liese, J and Belohradsky, BH. (2001) [Vaccination] <i>Klin Padiatr<\/i>, 213 Suppl 1, pp. A77 - 83."},{"key":"E00031","unstructured":"Schneerson, R and Robbins, JB. (1975) Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5 <i>N Engl J Med<\/i>, 292, pp. 1093 - 6."},{"key":"E00032","unstructured":"Bernasconi, NL and Traggiai, E and Lanzavecchia, A. (2002) Maintenance of serological memory by polyclonal activation of human memory B cells <i>Science<\/i>, 298, pp. 2199 - 202."},{"key":"E00033","unstructured":"Stachel, D and Futterer, A and Haas, RJ and Schmid, I. (2004) Enhanced lymphocyte proliferation responses in pediatric patients early after myelosuppressive chemotherapy <i>Pediatr Blood Cancer<\/i>, 43, pp. 644 - 50."},{"key":"E00034","unstructured":"Nilsson, A.(2004) <i> Regulation of antibody production in immunocompromised patients<\/i>. Stockholm : Karolinska Institutet."}],"container-title":["Acta Paediatrica"],"original-title":[],"link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F08035250500459717","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/08035250500459717\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:39:08Z","timestamp":1612975148000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/08035250500459717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6,1]]}},"alternative-id":["G308475222N8731P"],"URL":"https:\/\/doi.org\/10.1080\/08035250500459717","relation":{},"ISSN":["0803-5253"],"issn-type":[{"value":"0803-5253","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}